At MSL we are now able to carry out Virucidal testing methods for all appropriate PT groups. This dedicated facility allows us to carry out any required efficacy testing for any BPR dossier or to make claims which can put you a step above your competition, working with our customers we can ensure our expertise works best for you testing to the latest methods and draft documents available to work from.

New test methods and new requirements for products making Virucidal claims will be becoming available throughout 2019, and we want to work with our customers so they are always aware of these developments and can achieve these new benchmarks both quickly and efficiently.

If you are interested in taking advantage of our Virucidal testing capabilities contact our Projects team to discuss your requirements.